Sep 10, 2026 09:05AM
Sep 8, 2026 08:30AM
Jul 10, 2026 08:56AM
Jul 10, 2026 08:36AM
Jul 10, 2026 08:34AM
Jun 22, 2026 08:30AM
Jun 22, 2026 02:00AM Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D
Jun 12, 2026 06:09PM
Apr 22, 2026 01:09AM
Apr 22, 2026 01:05AM
Feb 17, 2026 08:30AM
Jan 23, 2026 01:00AM
Jan 15, 2026 06:02AM
Jan 5, 2026 02:06PM FDA approves Cablivi for rare blood disorder in kids
Jan 5, 2026 02:05PM
Dec 28, 2025 01:48AM
Dec 24, 2025 04:01AM
Dec 23, 2025 09:16AM
Dec 23, 2025 09:06AM
Dec 19, 2025 02:22PM
Dec 19, 2025 02:21PM Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Nov 25, 2025 01:00AM
Oct 28, 2025 02:00AM
Oct 20, 2025 07:30AM
Oct 20, 2025 07:30AM
Oct 2, 2025 08:00AM
Oct 2, 2025 08:00AM
Sep 25, 2025 02:23PM FDA removes safety restrictions for Sanofi thyroid cancer drug
Sep 22, 2025 01:00AM
Sep 10, 2025 08:00AM
Aug 29, 2025 05:50PM
Jul 22, 2025 11:57AM
Jun 2, 2025 05:40AM
Jun 2, 2025 01:25AM
May 21, 2025 07:23PM Sanofi (SNY) to acquire Vigil Neuroscience
May 21, 2025 07:15PM
May 14, 2025 12:32PM
May 14, 2025 12:30PM
Apr 30, 2025 07:00AM
Apr 24, 2025 01:39AM
Apr 21, 2025 04:05PM
Apr 18, 2025 11:15AM Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Apr 8, 2025 01:10PM
Mar 28, 2025 04:07PM
Mar 28, 2025 03:15PM
Mar 28, 2025 02:34PM
Mar 28, 2025 02:30PM
Mar 28, 2025 02:00AM
Mar 14, 2025 02:21PM Sanofi (SNY) adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season
Mar 14, 2025 02:18PM

332,776 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All